News

RiverNorth Funds Declare Preferred Dividends for Shareholders

RiverNorth Funds Declare Preferred Dividends for Shareholders

RiverNorth Funds Declare Preferred Dividends for Shareholders

RiverNorth Opportunities Fund, Inc. and RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. are excited to share news about their preferred dividends, ensuring that investors are kept well-informed about their investments. This announcement marks a significant step in the commitment to providing value and returns to their shareholders.

Details of the Preferred Dividends

In the upcoming fourth quarter, each fund has declared specific dividends as follows:

Ex, Record, and Payable Dates

The Ex Date, Record Date, and Payable Date are critical for investors to note:

  • Ex Date: November 1, 2024
  • Record Date: November 1, 2024
  • Payable Date: November 15, 2024

Fund and Dividend Information

Here’s a breakdown of the funds and their respective dividends:

  • Fund Name: RiverNorth Opportunities Fund, Inc.
    Preferred Stock Series: 6.000% Series A Perpetual Preferred Stock
    NYSE: RIVPRA
    Distribution Per Share: $0.37500
  • Fund Name: RiverNorth/DoubleLine Strategic Opportunity Fund, Inc.
    Preferred Stock Series: 4.375% Series A Cumulative Preferred Stock
    NYSE: OPPPRA
    Distribution Per Share: $0.27344
  • Fund Name: RiverNorth/DoubleLine Strategic Opportunity Fund, Inc.
    Preferred Stock Series: 4.750% Series B Cumulative Preferred Stock
    NYSE: OPPPRB
    Distribution Per Share: $0.29688

About RiverNorth Capital Management

Founded in 2000, RiverNorth Capital Management, LLC has grown into a prominent investment firm with a specialized focus on niche markets. As of the latest reports, the firm manages approximately $5.2 billion in assets, employing opportunistic strategies designed to capitalize on market inefficiencies. RiverNorth acts as an institutional investment manager for registered and private funds as well as separately managed accounts.

Understanding Distribution Sources

The preferred dividend distributions are tied to the Liquidation Preference of $25.00 per share. The dividends have been calculated based on the most current quarterly distribution rates:

  • RiverNorth Opportunities Fund, Inc. has a liquidating distribution rate of $0.37500 for its 6.00% Series A Preferred Stock.
  • RiverNorth/DoubleLine Strategic Opportunity Fund, Inc.’s 4.375% Series A has a rate of $0.27344.
  • For the 4.75% Series B, the rate also stands at $0.29688.

It’s essential for investors to note that distributions may not only come from net investment income but may also stem from short-term and long-term capital gains as well as return of capital. This means that the actual amounts and sources of the distributions may vary based on market experiences and tax regulations.

Risk Considerations

Investing in these funds does involve risks. Investors are encouraged to carefully evaluate the risks, charges, and expenses associated before proceeding with any investment. RiverNorth strongly advises reading the prospectus and consulting financial professionals to gain a clear understanding of these factors.

Consult a Professional

For detailed insights tailored to individual financial situations, it’s always wise to seek guidance from a tax advisor or legal expert regarding investments and possible tax implications following distributions.

Frequently Asked Questions

What are the declared preferred dividends for RiverNorth funds?

The funds have declared preferred dividends with specific amounts per share for their 6.000% Series A, 4.375% Series A, and 4.750% Series B preferred stocks.

When are the key dates for these dividends?

The Ex and Record dates are on November 1, 2024, with the Payable date on November 15, 2024.

How are the distributions calculated?

Distributions are calculated based on the Liquidation Preference of $25.00 per share and the current quarterly rates established for each fund's preferred stock series.

What risks are associated with investing in these funds?

Investors face risks such as loss of principal and should carefully review the related charges and expenses before investing.

Who should investors consult for tax questions?

It is recommended that investors speak with tax or legal professionals for guidance regarding their individual tax situations following investment decisions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 3

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading

Top 5 Most Recently Viewed Articles

Hargreave Hale AIM VCT PLC: New Share Allotment Explained

Updated Category News Views 114

Understanding the Latest Allotment of Shares for Hargreave Hale AIM VCT PLC Recently, Hargreave Hale AIM VCT PLC, known for its investment strategy focusing on AIM-listed companies, announced exciting developments regarding its share allotment. A prospectus was published for the offer of subscription for ordinary shares, aiming to raise up to £20 million. This initiative...

Continue Reading
Minovia Therapeutics Secures FDA Fast Track for MNV-201 Use

Updated Category News Views 203

Minovia's Remarkable Achievement in Myelodysplastic Syndrome Minovia Therapeutics Ltd. has made significant strides in the realm of biotechnology by receiving Fast Track Designation from the U.S. Food and Drug Administration (FDA) for its investigational compound, MNV-201. This designation is pivotal as MNV-201 aims to treat Myelodysplastic Syndrome (MDS), a serious and...

Continue Reading
Transforming Cybersecurity Training into Measurable Investment

Updated Category News Views 160

The Importance of Cybersecurity Training With the rise of cyber threats, it's essential for organizations to understand why investing in cybersecurity training is crucial. Companies like INE Security offer vital insights into how to effectively assess the return on investment (ROI) for these training initiatives. Cybersecurity training isn't merely a means of protection;...

Continue Reading
Inspirato Set to Reveal Q3 2024 Financial Results Soon

Updated Category News Views 79

Upcoming Q3 2024 Results Announcement Inspirato Incorporated (NASDAQ: ISPO), recognized as a premier luxury vacation club, has scheduled its release of financial and operating results for the third quarter of 2024. This announcement is anticipated to take place after market closure on Monday. As an entity that redefines luxury travel experiences, this news is particularly...

Continue Reading
Piedmont Lithium Reports Impressive Q4’24 Operational Results

Updated Category News Views 83

Piedmont Lithium's Stellar Q4 2024 Performance Piedmont Lithium Inc. (NASDAQ: PLL) has announced impressive operational results for the fourth quarter of 2024, marking a crucial step in the company's commitment to the North American lithium supply chain. The company successfully shipped approximately 55,700 dry metric tons (dmt) of spodumene concentrate during this...

Continue Reading